← Back to Search

AI-Enhanced Remote Therapy for Adolescent Violence

N/A
Recruiting
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6-months, 12-months
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare two versions of a multisession remote behavioral intervention for young people who have been injured in violence, in order to determine which is more effective in reducing violence involvement and associated negative behaviors.

Who is the study for?
This trial is for young people aged 14-24 who have been treated in the emergency department for a violent injury and own a smartphone. They must understand English and be able to consent. Those with mental incompetence, without a guardian if under 18, or involved in certain crimes like sexual assault are excluded.
What is being tested?
The study compares two remote therapy interventions aimed at reducing violence among adolescents: one standard version (S-RTI) and another enhanced by Artificial Intelligence (AI-RTI). It's set up as a randomized control trial where participants are randomly assigned to either intervention.
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects aren't expected. However, participants may experience discomfort discussing personal issues or stress from engaging with the intervention content.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6-months, 12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6-months, 12-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Aggression
Change in Victimization

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Remote Therapy InterventionExperimental Treatment1 Intervention
Youth will receive the maximal dose of six S-RTI therapy sessions delivered by a remote therapist with no alteration in intensity
Group II: Artificial Intelligence Remote Therapy InterventionExperimental Treatment1 Intervention
Youth will first receive a remote therapy session in the Emergency Department (ED). The RL system will then make decisions about the intensity of each subsequent therapy session (the initial decision is seven days post ED visit and bi-weekly \[i.e., every other two weeks\] thereafter) for the next 11 weeks. Potential treatment decisions include a 30-minute remote therapy session delivered via phone or video chat (mirroring the S-RTI), a less intensive tailored Motivational Interviewing (MI)-adherent electronic remote therapy (delivered by an electronic robot), or an assessment only without intervention.
Group III: Enhanced Usual CareActive Control1 Intervention
The youth's retaliatory risk will be assessed and a pamphlet with referrals for violence, substance use, and mental health services will be provided.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,863 Previous Clinical Trials
6,440,831 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,068 Previous Clinical Trials
2,746,704 Total Patients Enrolled

Media Library

Artificial Intelligence Remote Therapy Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04850274 — N/A
Adolescent Violence Research Study Groups: Artificial Intelligence Remote Therapy Intervention, Enhanced Usual Care, Remote Therapy Intervention
Adolescent Violence Clinical Trial 2023: Artificial Intelligence Remote Therapy Intervention Highlights & Side Effects. Trial Name: NCT04850274 — N/A
Artificial Intelligence Remote Therapy Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04850274 — N/A
~184 spots leftby Mar 2026